United Therapeutics (NASDAQ:UTHR) Cut to “Buy” at StockNews.com
StockNews.com cut shares of United Therapeutics (NASDAQ:UTHR – Free Report) from a strong-buy rating to a buy rating in a research note released on Friday. A number of other equities analysts have also issued reports on UTHR. Wedbush reaffirmed an outperform rating and issued a $308.00 target price (up from $307.00) on shares of United […]
More Stories
Trump Orders All Truckers to Be Proficient in Speaking, Reading English
By Jacob Burg President Donald Trump signed an executive order on April 28 requiring all commercial vehicle operators in the...
Border Residents Describe Dramatic Change in Trump’s First 100 Days
By Darlene McCormick Sanchez In Starr County, Texas, Marcus Canales told The Epoch Times that the past 100 days under...
How Major US Stock Indexes Fared April 28
By The Associated Press U.S. stocks drifted to a mixed, quiet finish Monday ahead of a week with several potential...
Muscle Memory Is Retained at the Protein Level, Study Finds
By George Citroner There’s no need to stress about losing hard-earned exercise gains. For the first time, science has validated...
House Panels to Hold Markups That Unveil Details of GOP Bill to Advance Trump’s Agenda
By Arjun Singh WASHINGTON—The U.S. House of Representatives, after returning from its spring recess, is set to begin drafting bills...
Canadians Vote in Pivotal Election, as Trump’s Tariffs, Annexation Talk Loom Large
By Tom Ozimek EDMONTON—Canadians headed to the polls on Monday in a pivotal election after a campaign shaped in part...